Hyperlipidemia and metabolic syndrome in schizophrenia:a study of the Northern Finland 1966 Birth Cohort

Hyperlipidemia and metabolic syndrome in schizophrenia:a study of the Northern Finland 1966 Birth Cohort

Abstract Schizophrenia is associated with a shortened life expectancy and increased somatic comorbidity with e.g. cardiovascular disorders. The purpose of this study was to evaluate hyperlipidemia and metabolic syndrome in schizophrenia and thus find specific risk factors for excess mortality and mo...

Full description

Bibliographic Details
Main Author:	Saari, K. (Kaisa)
Format:	Doctoral Thesis
Language:	English
Published:	University of Oulu 2005
Subjects:	antipsychotic agents cohort studies metabolic syndrome x psychotic disorders schizophrenia hyperlipidemia
Online Access:	http://urn.fi/urn:isbn:9514277287 http://nbn-resolving.de/urn:isbn:9514277287

Similar Items

The use of antipsychotic medication and its association with outcomes and brain morphometry in schizophrenia:the Northern Finland Birth Cohort 1966 Study
by: Moilanen, J. (Jani)
Published: (2016)

Brain MRI in subjects with schizophrenia and in adults born prematurely:the Northern Finland 1966 Birth Cohort Study
by: Tanskanen, P. (Päivikki)
Published: (2010)

Outcomes and their predictors in schizophrenia in the Northern Finland Birth Cohort 1966
by: Juola, P. (Pauliina)
Published: (2015)

Diagnostics and determinants of schizophrenia:the Northern Finland 1966 Birth Cohort Study
by: Moilanen, K. (Kristiina)
Published: (2011)

The association of lifetime antipsychotic and other psychiatric medications with cognition in schizophrenia:the Northern Finland Birth Cohort 1966 Study
by: Hulkko, A. (Anja)
Published: (2017)

Antipsychotic polypharmacy: Retrospective evaluation of cases with psychotic disorder followed in outpatient clinic (tur)
by: Şahabettin Çetin, et al.
Published: (2021-05-01)

Neurocognition as a predictor of outcome in schizophrenia in the Northern Finland Birth Cohort 1966
by: P. Juola, et al.
Published: (2015-09-01)

Parental psychosis, risk factors and protective factors for schizophrenia and other psychosis:the Northern Finland Birth Cohort 1966
by: Keskinen, E. (Emmi)
Published: (2015)

Risk factors and pathways leading to suicide with special focus in schizophrenia:the Northern Finland 1966 Birth Cohort Study
by: Alaräisänen, A. (Antti)
Published: (2010)

Nervous system medications and suicidal ideation and behaviour:the Northern Finland Birth Cohort 1966
by: Rissanen, I. (Ina)
Published: (2015)

Psychological intervention, antipsychotic medication or a combined treatment for adolescents with a first episode of psychosis: the MAPS feasibility three-arm RCT
by: Anthony P Morrison, et al.
Published: (2021-01-01)

Clinical, Biochemical and Genetic Variables Associated With Metabolic Syndrome in Patients With Schizophrenia Spectrum Disorders Using Second-Generation Antipsychotics: A Systematic Review
by: Marius H. Sneller, et al.
Published: (2021-03-01)

Symptomatic Resolution Among Chinese Patients With Schizophrenia and Associated Factors
by: Cheng-Ta Li, et al.
Published: (2010-05-01)

Paternal age, psychosis, and mortality:the Northern Finland 1966 Birth Cohort, Helsinki 1951–1960 Schizophrenia Cohort, and Finnish Nonaffective Psychosis Cohort
by: Miller, B. (Brian)
Published: (2011)

Plasma Levels of Long-Acting Injectable Antipsychotics in Outpatient Care: A Retrospective Analysis
by: Hýža M, et al.
Published: (2021-04-01)

Course of illness, outcome and their predictors in schizophrenia:the Northern Finland 1966 Birth Cohort study
by: Lauronen, E. (Erika)
Published: (2007)

Use of Atypical Antipsychotics in Long-Term Care Residents with Parkinson’s Disease and Comorbid Depression
by: Chekani F, et al.
Published: (2020-01-01)

Associations between symptom severity and well-being among Thai patients with schizophrenia: a cross-sectional analytical study
by: Teerapat Teetharatkul, et al.
Published: (2021-07-01)

A survey of the tardive dyskinesia induced by antipsychotic drugs in patients with schizophrenia.
by: Sahel Hemmati, et al.
Published: (2010-12-01)

A Survey of the Tardive Dyskinesia Induced by Antipsychotic Drugs in Patients with Schizophrenia
by: Naser tabibi, et al.
Published: (2010-11-01)

The conditions for the emergence of schizophrenia
by: Adam Pawlak, et al.
Published: (2019-04-01)

Age-related changes of superoxide dismutase activity in patients with schizophrenia
by: Đorđević Vladimir V., et al.
Published: (2017-01-01)

Pharmacoeconomic comparison of ziprasidone with other atypical oral antipsychotic agents in schizophrenia
by: Andrea Fagiolini, et al.
Published: (2011-11-01)

Polycystic Ovary Syndrome and Psychotic Disorder
by: Larissa Doretto, et al.
Published: (2020-06-01)

Differences between physicians' and nurse practitioners' viewpoints on reasons for clozapine underprescription
by: Cynthia Okhuijsen‐Pfeifer, et al.
Published: (2019-07-01)

Association between the HTR2C rs1414334 C/G gene polymorphism and the development of the metabolic syndrome in patients treated with atypical antipsychotics
by: José María Rico-Gomis, et al.
Published: (2016-07-01)

Switching Between Second-Generation Antipsychotics in Patients with Schizophrenia and Schizoaffective Disorder: 10-Year Cohort Study in Brazil
by: Izabela Fulone, et al.
Published: (2021-05-01)

Risperidone associated paralytic ileus in schizophrenia
by: Parthasarathy Ramamourthy, et al.
Published: (2013-01-01)

Glutamate neurocircuitry: theoretical underpinnings in schizophrenia
by: Thomas L Schwartz, et al.
Published: (2012-11-01)

Pharmacotherapy of schizophrenia
by: Shahin Akhondzadeh, et al.
Published: (2006-06-01)

Pharmacotherapy of schizophrenia
by: Shahin Akhondzadeh, et al.
Published: (2006-05-01)

Adolescent substance use and risk of psychosis in the Northern Finland Birth Cohort 1986
by: Mustonen, A. (Antti)
Published: (2018)

Prevalence of High Blood Pressure and its Relationship with Body Weight Factors among Inpatients with Schizophrenia in Taiwan
by: Yu-Li Lan, PhD, et al.
Published: (2012-03-01)

ANTIPSYCHOTICS IN LATE-LIFE SCHIZOPHRENIA – A NARRATIVE REVIEW
by: Matti Isohanni, et al.
Published: (2020-11-01)

Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: A retrospective cohort study
by: Berger Ariel, et al.
Published: (2012-08-01)

Adolescent predictors of adult social and psychiatric adversities:a prospective follow-up study of the Northern Finland 1966 Birth Cohort
by: Riala, K. (Kaisa)
Published: (2004)

Comorbid obsessive-compulsive symptoms in schizophrenia: contributions of pharmacological and genetic factors
by: Frederike eSchirmbeck, et al.
Published: (2013-08-01)

Functional recovery in patients with schizophrenia: recommendations from a panel of experts
by: Guillermo Lahera, et al.
Published: (2018-06-01)

A systematic review on clinical management of antipsychotic-induced sexual dysfunction in schizophrenia
by: Anna Maria Niccolai Costa, et al.

Serum prolactin level in patients taking olanzapine
by: Diganta Das, et al.
Published: (2015-01-01)